Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-01-21FDA Approved: GEMFIBROZIL — Supplemental Application (Exelan Pharmaceuticals, Inc.)
The FDA approved a supplemental application for gemfibrozil from Exelan Pharmaceuticals, Inc. (ANDA 077836).
-
FDA approval · 2015-12-23FDA Approved: LIPOFEN — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for LIPOFEN (fenofibrate) submitted by ANI Pharmaceuticals, Inc.
-
FDA approval · 2015-12-11FDA Approved: NIACIN — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's original application for NIACIN (nicotinic acid) as a generic product.
-
FDA approval · 2015-11-30FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for pravastatin sodium from Teva Pharmaceuticals USA, Inc., authorizing a generic pravastatin produc…
-
FDA approval · 2015-11-18FDA Approved: FENOFIBRIC ACID — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for Fenofibric Acid submitted by Amneal Pharmaceuticals of New York LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-11-17FDA Approved: AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM — Supplemental Application (Dr. Reddy's Laboratories Inc)
FDA approved a supplemental application for amlodipine besylate and atorvastatin calcium from Dr. Reddy's Laboratories Inc, enabling its mar…
-
FDA approval · 2015-11-16FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for a generic amlodipine and atorvastatin combination from Mylan Pharmaceuticals Inc., under the AND…
-
FDA approval · 2015-11-09FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for atorvastatin calcium (generic) by Mylan Pharmaceuticals, confirming an additional aspect of its …
-
FDA approval · 2015-10-15FDA Approved: SIMVASTATIN — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for simvastatin submitted by NorthStar Rx LLC.
-
FDA approval · 2015-10-09FDA Approved: NIACIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' supplemental application for NIACIN (niacin), a generic product. This decision constitutes a supplementa…
-
FDA approval · 2015-10-06FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Sun Pharmaceutical Industries Inc.)
The FDA approved a supplemental application for atorvastatin calcium from Sun Pharmaceutical Industries Inc., granting regulatory approval f…
-
FDA approval · 2015-09-16FDA Approved: GEMFIBROZIL — Original Application (NorthStar Rx LLC)
FDA approved an original ANDA for a generic gemfibrozil product manufactured by NorthStar Rx LLC.
-
FDA approval · 2015-09-15FDA Approved: GEMFIBROZIL — Supplemental Application (Northstar RxLLC)
FDA approved a supplemental application for Gemfibrozil under Northstar RxLLC's ANDA, authorizing changes to the approved product.
-
FDA approval · 2015-08-31FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' Supplemental NDA for fenofibrate, authorizing approved changes to this lipid-lowering medicine. This act…
-
FDA approval · 2015-08-17FDA Approved: FENOFIBRATE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin's original application for fenofibrate (generic fenofibrate), expanding access to a lipid-lowering option.
-
FDA approval · 2015-07-09FDA Approved: NIACIN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for NIACIN (nicotinic acid) from Sun Pharmaceutical Industries, Inc., relating to an additional appr…
-
FDA approval · 2015-07-09FDA Approved: NIACIN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries' supplemental application for NIACIN (nicotinic acid).
-
FDA approval · 2015-06-26FDA Approved: EZETIMIBE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved the original application for ezetimibe (generic) by Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2015-06-01FDA Approved: CRESTOR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for CRESTOR (rosuvastatin) submitted by AstraZeneca Pharmaceuticals LP.
-
EMA approval · 2015-05-22First-in-class treatment to lower cholesterol
EMA announces a first-in-class treatment to lower cholesterol, representing a novel mechanism for managing the condition.
-
FDA approval · 2015-04-28FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Quallent)
FDA approved a supplemental application for atorvastatin calcium (Quallent).
-
FDA approval · 2015-04-17FDA Approved: FENOFIBRIC ACID — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for fenofibric acid from Amneal Pharmaceuticals of New York LLC, resulting in a change to its ap…
-
FDA approval · 2015-04-15FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Pravastatin Sodium submitted by Aurobindo Pharma Limited, approving this generic statin product.
-
FDA approval · 2015-04-06FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Quallent)
The FDA approved a supplemental application for atorvastatin calcium from Quallent, granting updated regulatory approval for this generic st…
-
FDA approval · 2015-03-23FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for the fixed-dose combination of amlodipine and atorvastatin, manufactured by Prasco Laboratories. …